Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats

Drug and Alcohol Dependence

Volumn 97, Issue 3, 2008, Pages 207-215

  Peng, Xiao Qing ^a   Li, Xia ^a   Li, Jie ^a   Ramachandran, P Veeraraghavan ^b   Gagare, Pravin D ^b   Pratihar, Debarshi ^b   Ashby Jr , Charles R ^c   Gardner, Eliot L ^a   Xi, Zheng Xiong ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

Author keywords

Cocaine; Dopamine; GABA; Gabapentin; Relapse; Self administration

Indexed keywords

4 AMINOBUTYRIC ACID; COCAINE; DOPAMINE; GABAPENTIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFECT; DRUG SELF ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RELAPSE;

AMINES; ANIMALS; ANTI-ANXIETY AGENTS; COCAINE; COCAINE-RELATED DISORDERS; CYCLOHEXANECARBOXYLIC ACIDS; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; IMPULSE CONTROL DISORDERS; MALE; NUCLEUS ACCUMBENS; RATS; RATS, LONG-EVANS; RECURRENCE; SELF ADMINISTRATION; VASOCONSTRICTOR AGENTS;

ANIMALIA; RATTUS;

EID: 49349097996     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.09.019     Document Type: Article

References (60)

1. Berger S.P., Winhusen T.M., Somoza E.C., Harrer J.M., Mezinskis J.P., Leiderman D.B., Montgomery M.A., Goldsmith R.J., Bloch D.A., Singal B.M., and Elkashef A. A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction 100 Suppl. 1 (2005) 58-67
2. Bisaga A., Aharonovich E., Garawi F., Levin F.R., Rubin E., Raby W.N., and Nunes E.V. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend. 81 (2006) 267-274
3. 50 indices. Behav. Brain Res. 144 (2003) 243-247
4. Brodie J.D., Figueroa E., and Dewey S.L. Treating cocaine addiction: from preclinical to clinical trial experience with γ-vinyl GABA. Synapse 50 (2003) 261-265
5. Cameron D.L., and Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14 (1994) 6763-6767
6. Campbell U.C., Lac S.T., and Carroll M.E. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143 (1999) 209-214
7. Carlezon Jr. W.A., and Wise R.A. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J. Neurosci. 16 (1996) 3112-3122
8. Dewey S.L., Chaurasia C.S., Chen C.E., Volkow N.D., Clarkson F.A., Porter S.P., Straughter-Moore R.M., Alexoff D.L., Tedeschi D., Russo N.B., Fowler J.S., and Brodie J.D. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25 (1997) 393-398
9. Dewey S.L., Morgan A.E., Ashby Jr. C.R., Horan B., Kushner S.A., Logan J., Volkow N.D., Fowler J.S., Gardner E.L., and Brodie J.D. A novel strategy for the treatment of cocaine addiction. Synapse 30 (1998) 119-129
10. B receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 28 (2003) 510-518
11. Eckstein-Ludwig U., Fei J., and Schwarz W. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs. Br. J. Pharmacol. 128 (1999) 92-102
12. Filip M., Frankowska M., Gotda A., Zaniewska M., Vetulani J., and Przegaliński E. Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization. Eur. J. Pharmacol. 541 (2006) 163-170
13. Filip M., Frankowska M., Zaniewska M., Gotda A., Przegaliński E., and Vetulani J. Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats. Psychopharmacology 192 (2007) 17-26
14. Gardner E.L. What we have learned about addiction from animal models of drug self-administration. Am. J. Addict. 9 (2000) 285-313
15. Gasior M., Ungard J.T., and Witkin J.M. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J. Pharmacol. Exp. Ther. 290 (1999) 1148-1156
16. A receptor modulator, inhibits the effects of cocaine on locomotor activity and extracellular dopamine in the nucleus accumbens shell without tolerance liability. J. Pharmacol. Exp. Ther. 287 (1998) 58-66
17. Goa K.L., and Sorkin E.M. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs 46 (1993) 409-427
18. González G., Desai R., Sofuoglu M., Poling J., Oliveto A., Gonsai K., and Kosten T.R. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 87 (2007) 1-9
19. González G., Sevarino K., Sofuoglu M., Polng J., Oliveto A., Gonsai K., George T.P., and Kosten T.R. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 98 (2003) 1625-1632
20. Gorelick D.A., Gardner E.L., and Xi Z.-X. Agents in development for the management of cocaine abuse. Drugs 64 (2004) 1547-1573
21. Götz E., Feuerstein T.J., Lais A., and Meyer D.K. Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung 43 (1993) 636-638
22. Grabowski J., Rhoades H., Silverman P., Schmitz J.M., Stotts A., Creson D., and Bailey R. Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J. Clin. Psychopharmacol. 20 (2000) 305-310
23. Haney M., Hart C., Collins E.D., and Foltin R.W. Smoked cocaine discrimination in humans: effects of gabapentin. Drug Alcohol Depend. 80 (2005) 53-61
24. Haney M., Ward A.S., Foltin R.W., and Fischman M.W. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology 155 (2001) 330-337
25. Hart C.L., Haney M., Collins E.D., Rubin E., and Foltin R.W. Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend. 86 (2007) 274-277
26. Hart C.L., Ward A.S., Collins E.D., Haney M., and Foltin R.W. Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend. 73 (2004) 279-287
27. Henry D.J., and White F.J. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J. Neurosci. 15 (1995) 6287-6299
28. Honmou O., Oyelese A.A., and Kocsis J.D. The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis. Brain Res. 692 (1995) 273-277
29. Itzhak Y., and Martin J.L. Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice. Psychopharmacology 151 (2000) 226-233
30. Johnson B.A. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 19 (2005) 873-896
31. Kampman K.M., Pettinati H., Lynch K.G., Dackis C., Sparkman T., Weigley C., and O'Brien C.P. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 75 (2004) 233-240
32. Kiyatkin E.A., and Rebec G.V. Dopamine-independent action of cocaine on striatal and accumbal neurons. Eur. J. Neurosci. 12 (2000) 1789-1800
33. Kushner S.A., Dewey S.L., and Kornetsky C. Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds. Psychopharmacology 133 (1997) 383-388
34. Kushner S.A., Dewey S.L., and Kornetsky C. The irreversible γ-aminobutyric acid (GABA) transaminase inhibitor γ-vinyl-GABA blocks cocaine self-administration in rats. J. Pharmacol. Exp. Ther. 290 (1999) 797-802
35. Li X., Peng X.-Q., Gilbert J., Xi Z.-X., and Gardner E. Gabapentin has no effect on cocaine-primed relapse and cocaine-induced increases in dopamine in the nucleus accumbens. Abstracts of the 68th Annual Scientific Meeting of the College on Problems of Drug Dependence, 2006. Phoenix, Arizona (2006) (abstract # 460)
36. Löscher W., Hönack D., and Taylor C.P. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci. Lett. 128 (1991) 150-154
37. Markowitz J.S., Finkenbine R., Myrick H., King L., and Carson W.H. Gabapentin abuse in a cocaine user: implications for treatment?. J. Clin. Psychopharmacol. 17 (1997) 423-424
38. Mathiesen O., Moiniche S., and Dahl J.B. Gabapentin and postoperative pain; a qualitative and quantitative systematic review, with focus on procedure. BMC Anesthesiol. 7:6 (2007). http://www.biomedcentral.com/1471-2253/7/6 (published online 07 July 07 at http://www.biomedcentral.com/1471-2253/7/6)
39. Morris G.L. Gabapentin. Epilepsia 40 Suppl. 5 (1999) S63-S70
40. Myrick H., Henderson S., Brady K.T., and Malcolm R. Gabapentin in the treatment of cocaine dependence: a case series. J. Clin. Psychiatry 62 (2001) 19-23
41. 1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology 155 (2001) 338-347
42. Peng X.-Q., Xi Z.-X., Gilbert J., Campos A., Dewey S.L., Schiffer W.K., Brodie J.D., Ashby C.R., and Gardner E.L. Gamma-vinyl GABA, but not gabapentin, inhibits cocaine-triggered reinstatement of drug-seeking behavior in the rat. Abstracts of the 34th Annual Meeting of the Society for Neuroscience, 2004. San Diego, CA (2004) (abstract # 691.8)
43. Pereira M.B., Freitas R.L., Assis M.A., Silva R.F., Fonteles M.M., Freitas R.M., and Takahashi R.N. Study pharmacologic of the GABAergic and glutamatergic drugs on seizures and status epilepticus induced by pilocarpine in adult Wistar rats. Neurosci. Lett. 419 (2007) 253-257
44. Raby W.N. Gabapentin therapy for cocaine cravings. Am. J. Psychiatry 157 (2000) 2058-2059
45. Raby W.N., and Coomaraswamy S. Gabapentin reduces cocaine use among addicts from a community clinic sample. J. Clin. Psychiatry 65 (2004) 84-86
46. Reccoppa L., Malcolm R., and Ware M. Gabapentin abuse in inmates with prior history of cocaine dependence. Am. J. Addict. 13 (2004) 321-323
47. B agonists as a pharmacotherapy for cocaine addiction. Physiol. Behav. 86 (2005) 18-20
48. Roberts D.C.S., Andrews M.M., and Vickers G.J. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15 (1996) 417-423
49. Schiffer W.K., Marsteller D., and Dewey S.L. Sub-chronic low dose γ-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine. Psychopharmacology 168 (2003) 339-343
50. Shaham Y., Shalev U., Lu L., De Wit H., and Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168 (2003) 3-20
51. Shoptaw S., Yang X., Rotheram-Fuller E.J., Hsieh Y.C., Kintaudi P.C., Charuvastra V.C., and Ling W. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J. Clin. Psychiatry 64 (2003) 1440-1448
52. 3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur. J. Pharmacol. 244 (1993) 293-301
53. Tanabe M., Murakami H., Honda M., and Ono H. Gabapentin depresses C-fiber-evoked field potentials in rat spinal dorsal horn only after induction of long-term potentiation. Exp. Neurol. 202 (2006) 280-286
54. Taylor C.P., Gee N.S., Su T.-Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., and Singh L. Summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29 (1998) 233-249
55. Timmerman W., Bouma M., De Vries J.B., Davis M., and Westerink B.H.C. A microdialysis study on the mechanism of action of gabapentin. Eur. J. Pharmacol. 398 (2000) 53-57
56. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2005. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. http://www.fda.gov/cder/guidance/index.htm. (accessed on October 19, 2007).
57. Wang Y., and Welty D.F. The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using microdialysis-pharmacokinetic approach. Pharm. Res. 13 (1996) 398-403
58. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6 (1996) 243-251
59. 3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost - variable-payoff fixed-ratio cocaine self-administration in rats. Eur. J. Neurosci. 21 (2005) 3427-3438
60. 1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J. Neurosci. 26 (2006) 8531-8636